Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience.
Picard
C
C
Hayette
S
S
Bilhou-Nabera
C
C
Cayuela
J M
JM
Delabesse
E
E
Frenoy
N
N
Preudhomme
C
C
Dupont
M
M
Bastard
C
C
Bories
D
D
Vaerman
J L
JL
Davi
F
F
Dastugue
N
N
Raynaud
S
S
Lafage
M
M
Deschaseaux
F
F
Fest
T
T
Gaub
M P
MP
Lhéritier
V
V
Thomas
X
X
Charrin
C
C
Boucheix
C
C
Dombret
H
H
Macintyre
E
E
Fière
D
D
Gabert
J
J
D000293:Adolescent; D000328:Adult; D002051:Burkitt Lymphoma / Q000235:genetics*; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D018398:Homeodomain Proteins / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011379:Prognosis; D011446:Prospective Studies; D012333:RNA, Messenger / Q000032:analysis*; D020133:Reverse Transcriptase Polymerase Chain Reaction
D018398:Homeodomain Proteins; C113855:MLL-AF4 fusion protein, human; D015514:Oncogene Proteins, Fusion; D012333:RNA, Messenger; C089847:E2A-Pbx1 fusion protein; D051788:Myeloid-Lymphoid Leukemia Protein; D016044:Fusion Proteins, bcr-abl